Phenotypic variation of an ALK-positive large-cell neuroendocrine lung carcinoma with carcinoid morphology during treatment with ALK inhibitors

Histopathology. 2018 Mar;72(4):707-710. doi: 10.1111/his.13388. Epub 2017 Dec 11.

Authors

Delphine Hoton^{1

2}, Yves Humblet³, Louis Libbrecht¹

Affiliations

¹ Department of Pathology, St Luc University Hospital, Brussels, Belgium.
² Clinical and Experimental Research Institute (IREC), Brussels, Belgium.
³ Department of Oncology, St Luc University Hospital, Brussels, Belgium.

PMID: 28888040
DOI: 10.1111/his.13388

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Anaplastic Lymphoma Kinase
Carcinoid Tumor / pathology
Carcinoma, Large Cell / pathology*
Carcinoma, Neuroendocrine / pathology*
Female
Humans
Lung Neoplasms / pathology*
Phenotype
Receptor Protein-Tyrosine Kinases / analysis
Receptor Protein-Tyrosine Kinases / biosynthesis

Substances

ALK protein, human
Anaplastic Lymphoma Kinase
Receptor Protein-Tyrosine Kinases